创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

LI Hongyuan, WANG Kunmiao, YAO Jianhua, LIU Zhihua, ZHU Haizhou, WANG Xiaohui. Research Progress in the Development of Nicotine as a Medicine[J]. Progress in Pharmaceutical Sciences, 2019, 43(1): 34-41.
Citation: LI Hongyuan, WANG Kunmiao, YAO Jianhua, LIU Zhihua, ZHU Haizhou, WANG Xiaohui. Research Progress in the Development of Nicotine as a Medicine[J]. Progress in Pharmaceutical Sciences, 2019, 43(1): 34-41.

Research Progress in the Development of Nicotine as a Medicine

  • Most of the various chemicals produced during smoking are harmful to health. Nicotine, the major substance that leads to smoking addiction, can easily penetrate blood-brain-barrier and produce various effects on the nervous system. In recent years, it has been discovered that nicotine has the potential to be developed into a medicine. Epidemiological studies have shown that the incidence of some major diseases including inflammation and neurodegenerative diseases in smokers is much lower than in non-smokers. This paper discussed the anti-inflammatory and neuroprotective effects of nicotine in the pathogenesis and progression of some diseases, providing important theoretical evidence for the development of nicotine into medicine.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return